News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

HemCon Medical Technologies, Inc. And ProMetic BioSciences, Inc. Announce Collaborative Development Agreement


3/3/2009 9:22:07 AM

PORTLAND, Ore. & CAMBRIDGE, England--(BUSINESS WIRE)--HemCon Medical Technologies Inc. (“HemCon”), a leading global developer of advanced medical products, today announced a new collaborative development agreement with ProMetic Life Sciences Inc.’s (“ProMetic”) UK-based division, ProMetic BioSciences Ltd that specializes in separation products and technologies for use in the manufacturing of biopharmaceutical products. Together, HemCon and ProMetic will develop and validate a sterile, single-use antibody capture device for the removal of isoagglutinin antibodies.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES